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A VARIETY of neoplasms has been induced by the injection of polycyclic
hydrocarbons, urethane, alkylating agents and nitrosamines into newborni mice
(Pietra, Spencer and Shubik, 1959; Pietra, Rappaport and Shubik. 1961 Fiore-
Donati, Chieco-Bianchi, de Benedictis and Maiorano, 1961; Roe. Mitchley and
Walters, 1963; Toth, Magee and Shubik, 1964). The experiments to be described
were designed to investigate the sensitivity of newborn mice with a viewN to using
the technique for screening compounds for carcinogenic activity. A range of
doses of DMBA has been tested for activity in newborn mice, and the sensitivity
of the newborn to the induction of lung tumours has been coinpared witlh that of
sucklings and young adults.
MATERIALS AND METHODS
Chemical agents.-9,10-Dimethyl-1,2-benzanthracene (DMBA) was obtained
from Roche Products Ltd. and gelatine powder from British Drug Houses. A
suspension of DMBA in 300 aqueous gelatine was prepared by adding an acetone
solution of the compound to aqueous gelatine warmed to 560 C. The acetone
was driven off in a stream of nitrogen while the temperature was maintainied at
this level. The dose of DMBA administered to each mouse was cointainied in
002 ml. aqueous gelatine.
Mice.-BALB 'c (Bittner agent free) mice were used in both experiments.
The line was originally obtained from Dr. H. B. Andervont of the National
Cancer Institute, Bethesda, Maryland, and has been maintained in this Institute
by brother-sister mating since 1952. The mice were housed in metal cages and
given water and fed a cubed diet (Diet 86, Messrs. Dixon and Sons, Ware, Herts.)
ad libitum. Every mouse was vaccinated at 6 to S weeks of age as a precaution
against ectromelia. Suckling and young adult mice were injected subcutaneously
in the flank and newborn mice in the scapular region. In the case ofthe newborn,
the needle was inserted at the root of the tail and the material was deposited in
the scapular region to minimise leakage. Losses due to cannibalism by the
mother were small.
The mice were weaned at 4 weeks, numbered on the ears and housed. 4-6 to a
cage, according to group and sex. They were inspected every day. and examined
thoroughly once a week, and sick mice were killed and autopsied. All surviving
mice were killed 40 weeks after the day of injection and examined post mortem.DMBA INDUCTION OF MOUSE LUNG TUMOURS
Adenoimias oni the surface of the lungs were counted and the diameter of the
largest tumour was measured. All lung tumours larger than 3 mm. diameter and
a prol)ortion of the smaller adenomas were fixed in Bouin's fixative and sectioned.
Lesionis from other organs, which were definitely, or possibly neoplastic, were also
takeni for microscopical examination.
Experbient 1
Litters were allotted randomly to 8 groups. IDMBA was administered to
d groups in logarithmically spaced doses of 40, 20, 10, 5, 2-5, 1P25 and 0 625 pug.
The control group received 002 ml. of 3%o aqueous gelatine. All of the mice
were inijected when less than 24 hours old.
T'he results are presented in Table I. Response was measured by lung tumour
incidence, the mean number of lung tumours per surviving mouse, and the mean
size of the largest tumour per tumour-bearing survivor.
A dose as small as 0625 ,Ig. DMiBA gave rise to a significantly greater incidence
oflunig tumours in males, as compared with the controls (P < 0.01), but in females
100- .0
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jxg, DMBA
Fi('.. I.-Incidence of lung tumrous in mice 40 weeks after neonatal injection
with a ranige of (loses Of DMBA.
the difference was insignificant at doses smnaller than 2-5 ,ug. (Fig. 1). The mean
nodule count and mean size of the largest tumour increased with increasing
dosages, but the tumour dose relationship was not linear (Fig. 2-5). Differences
in the mean number of tumours per survivor, significant at the 500 level, occurred
betweeni treated and control mice with a dose of 2-5 jug. in males and 10 ,Ig. in
females. There were too few controls with lung tumours to make a just com-
parison between the size of the largest tumours.
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FIG. 2.-Mean numbers of lung tumours in males injected with a range of doses
of DMBA.
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FIG. 3.-Mean numbers of lung tumours in females injected with a range of doses
of DMBA.
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FIG. 4. Mean sizes of largest lung tumours in groups of males injected with a
range of doses of DMBA.
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FIG. 5.-Mean sizes of largest lung tumours in groups of females injected with a
range of doses of DMBA.
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Microscopic examination of the lungs showed that most of the adenomas were
situated close to the pleura and would therefore have been seen on gross inspection.
Because of the difficulty of distinguishing benign and malignant tumours a new
system of classifying mouse pulmonary tumours has been used. Six classes of
tumours are recognised. Class 1 includes small well-circumscribed adenomas.
Tumours which have invaded adjacent bronchi but have spread no further are
classified as Class 2. Classes 3 to 6 are definitely malignant: Class 3 consists of
tumours which have given rise to metastases (frequently multiple) elsewhere in
the lunig; Class 4 tumours have invaded the mediastinum; Class 5 show evidence
oftranspleural spread or invasion ofthe intercostal muscles; and Class 6 tumours
have distant metastases.
Mice which received 40, 20 or 10 ,ag. DMBA, but not those which received
smaller doses, developed Class 3 tumours. No tumours of Classes 4, 5 or 6 were
seen in this experiment.
Malignant lymphoma was recorded in 11 mice which received 1P25 ,ug. DMBA
or a higher dose. One male injected with 40 ,ug. DMBA developed a spindle-cell
sarcoma at the injection site.
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FIC'. 6.-Incidence of lung tumours in mice injected with 15 ,ug. DABA at
different ages and body weights, and killed 40 weeks after injection.
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Experiment 2
There were six treated and three control groups among which litters were
randomly divided. Newborn mice (< 24 hours old), whose body weights were
between 1P2 and 1-8 g. with a mean of 1P5 g., received a single injection of 15 ,ug.
DMBA in aqueous gelatine (Group 1) or aqueous gelatine alone (Group 7). Mice
weighing 6 g. ± 0 5 g., which were sucklings of 2-3 weeks of age, were given
one injection of 15 ,tg. DMBA (Group 2), two injections of 30 ,ug. DMBA (Group 3)
or two injections ofaqueous gelatine (Group 8). Young adult mice which weighed
mm.
. 0
:L.
5-
' l a.
EI
e
,
-3
L.
.0
rc
*51
z a
a,
0 Y.
VI1
c
a
0
c cf
03
c
c
do
a
-IC
0~
ft
B OD DY W EI G HT(g)
FIG. 7. Mean numbers of lung tumours and mean sizes of largest lung tumours in
mice injected with 15 ,ug. DMBA at different ages and body weights.
18 g. ± 2 g. received one injection of 15 ,tg. DMBA (Group 4), two injections of
30 ,ug. DMBA (Group 5), six injections of 30 ,tg. DMBA (Group 6) or six injections
of aqueous gelatine (Group 9). Where there were two injections, one was given
into each flank on the same day, and where there were six injections, three were
given into each flank on three successive days.
Table II shows the results in full. The effect of 15 Itg. DMBA in mice of
different ages and body weights is shown in Fig. 6 and 7. The incidence of lung
tumours was significantly greater in mice injected when they weighed 1P5 g. than
in mice weighing 6 g. (,i-P < 0.01; -P = 0.05) or 18 g. (i- P < 001
$-P < 0.001). The differences between the 1-5 and 6 g., 1-5 and 18 g., and 6 g.
and 18 g. groups with regard to mean nodule count were significant at the 1%
level for males and the 0.1% level for females. The mean size of the largestDMBA INDUCTION OF MOUSE LUNG TUMOURS
tumour was significantly greater (P <0(001) in mice injected (with 15 ,tg.) at
1.5g. than at 6g. or 18g.
When the dose of DMBA was related to body weight, i.e. 15 jtg. to 1-5 g. mice,
60 jug. to 6 g. mice, or 180 Itg. to 18 g. mice, the incidence of mice with pulmonary
adenomas was 1000/ in all cases, both in males and females (Table IT). Females
injected neonatally had significantly higher nodule counts than female mice
treated as sucklings (P < 0.001) or young adults (P = 0.01) (Fig. 8). The
DMBA oDMBA
-treated + Controls Treated U Controls
°,30 -ISy i5jg.
ISg. 69lg 5.6.1g 59 .1g 5.6.19
CL
*gB 6.
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1*5g. 6g. N8g. .15g. 6g. .18g. 1'5g. 6g. l18g. 1.5g. 6g. 18g.
BO0DY WElIG1HT(g.)
Fi(c. S.-Alean nuinbeis of lung tumours in mice injected at different ages, when
the (dose of DMBA was proportional to the body weight.
results for males were slightly, but not significantly, different. When the means
for size of the largest tumours were compared there was a significant difference
(P < 0-001) between males treated as newborns and males treated as sucklings
or adults, but not between females ofdifferent groups (Fig. 9).
Malignant lung tumours occurred in mice of both sexes which received 15 ,Ig.
I)MBA at 1-5 g., 60 ,ug. at 6 g., or 180 ,ug. at 18 g. There were two Class 5 adeno-
carcinomas in mice treated when newborn.
Ten mice (5 i, 5 J) in Group 6, which received 180 ,ug. DMBA (90 ,tg. into
each flank) developed pleomorphic or spindle cell sarcomas at one or two injection
sites. In addition, two females had adenocarcinomas of mammary gland origin.
One male in Group 2 had a multifocal parotid gland tumour histologically
identical with those induced by the introduction ofthe polyoma virus into newborn
mice (Stewart, 1955).
Malignant lymphomas occurred in 1 female in Group 3, 1 female in Group 5
and 2 females and 1 male in Group 6.
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FIG. 93 Moean sizes of largest lung tumours in maice injected1 at different ages,
xmhen the dose of DMBA was propo)rtional to the bodyr weight.
DISCUSSION
The induction of pulmonary tumours in mice is a useful quantitative measure
of carcinogenic activity. The majority of the lung adenomas are visible on the
pleural surface, so it is possible to count them fairly accurately with the naked eye.
Using the technique of injecting carcinogens intravenously into A strain mice
Andervont and Shimkin (1940) showed that the reaction of the lungs to carcino-
gens is uniform: weak carcinogens or small doses of potent carcinogens gave rise
to a significantly greater incidence of tumours than seen in untreated or solvent-
treated control groups. When the dose of the carcinogen was increased, or a
more potent carcinogen used, the multiplicity as well as the incidence of tumours
increased. With 3-methylcholanthrene Shimkin (1940) found that the number
of tumour-bearing mice and the average number of lung tumours per mouse were
directly proportional to the dose. A later analysis of dose-response data using
methylcholanthrene Shimkin and McClelland (1949) showed that the lungs of
young adult strain A mice were sensitive enough a test medium to distinguish
between doses of 00625, 0125 025 and 05 mg. The mice were killed after 8.
13 or 18 weeks. Employing the same technique, but using dibenzanthracene as
the carcinogen, Heston and Schneiderman (1953) demonstrated that the lung
tumour-dose relationship was linear.
By injecting newborn BALB/c mice, subcutaneously, with DMBA we have
shown that lung tumour incidence, multiplicity and size increased with dose,
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although the tumour dose relationship was not linear. Kelly and O'Gara (1961)
injected newborn non-inbred albino mice with five logarithmically spaced dose
levels of dibenzanthracene or methylcholanthrene and found that the percentage
of mice developing lung tumours and the number of tumours per mouse increased
with dosage. The mean nodule count was the more sensitive index of response to
the carcinogen.
A dose of 15 ,ug. DMBA gave rise to a significantly greater incidence, multi-
plicity and size of lung tumours when injected into newborn mice (1.5 g.) than
into sucklings (6 g.) or young adults (18 g.). However, when the dose of DMBA
was related to body weight, mice injected neonatally were hardly more sensitive
than older mice. There was a significant difference between mean nodule counts
in females, but not males, and between the mean size of the largest tumour in
males, but not females. This result is therefore somewhat equivocal.
The results of Kelly and O'Gara are also equivocal. In their first paper (1961)
the response in newborns was found to be greater than that in 3 or 6-week-old
animals, whether the dose (of dibenzanthracene or methyleholanthrene) was
expressed as mg./kg. or mg./animal. The incidence oflung tumours and the mean
nodule count were recorded at 8, 16 and 24 weeks after injection. In a later
experiment, however, (O'Gara and Kelly, 1963) the highest mean lung tuinour
count at 24 weeks was in mice injected at 2 weeks of age: on a mg.7kg. basis this
mean nodule count was six times higher than that in mice injected as newborns.
Newborn mice respond to very small doses of carcinogens: to 0-625 ,ag. DMBA
for the induction of pulmonary adenomas and to 0 005 ,ug. methylcholanthrene or
0 003 ,ag. dibenzanthracene for the induction of fibrosarcomas at the injection site
(O'Gara, Kelly and Mantel, 1962). But this response is not necessarily due to a
special sensitivity because, on a mg./kg. basis, these doses are equivalent to doses
which would be carcinogenic in adults. Except in the development of malignant
lymphoma, which is probably related to the immaturity of the thymus (Pietra,
Spencer and Shubik, 1959; Fiore-Donati, Chieco-Bianchi, de Benedictis and
Maiorano, 1961; Rappaport and Baroni, 1962), newborn mice appear to be hardly
more sensitive than adults to carcinogenic hydrocarbons.
SUMMARY
1. Groups of newborn (less than 24 hours old) BALB/c mice were injected.
subcutaneously, with 40, 20, 10, 5, 2-5, 1-25 or 0 625 ,ug. DMBA in 30° aqueous
gelatine. A control group received aqueous gelatine only. Lung tumour incidence.
multiplicity and size increased with dose, but the tumour'dose relationship was
not linear. 0)625 jig. increased the tumour incidence above the control level in
males; 2 5 jtg. did so in females.
2. 15 jag. DMBA gave rise to a significantly greater incidence of lung tumours
when administered to newborn mice (body weight 1.5 g.) than to sucklings
(body weight 6 g.) or young adults (body weight -18 g.). The mean nodule
count was higher and size of the largest tumour greater in the neonatally-injected
groups.
3. When the dose of DMBA was related to the body weight, i.e. 15 ag./1 5 g..
60 jag./6 g., or 180 jag. 18 g. the newborn mice were only slightly more sensitive
than older animals.
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